Roche at the 2018 ASH's 60th Annual Meeting

Agenda:

Welcome

Roche Hematology Strategy and Key data in CLL and AML

Key Data in NHL Nancy Valente, M.D., Vice President, Global Head of Hematology Development

Key Data in Hemophilia A Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader

Karl Mahler, Head of Investor Relations, Roche

Sandra Horning, M.D., Chief Medical Officer and Head of Global Product Development

Nancy Valente, M.D., Vice President, Global Head of Hematology Development

Gallia Levy, M.D., Group Medical Director, Hemlibra Global Development Leader

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Roche has hosted a live audio webcast and conference call on Tuesday, 4 December 2018.

Investors

Downloads

PDF

PDF